Why Big Pharma may not want Trump's streamlined FDA
Big Pharma CEOs may not welcome Donald Trump's plans to speed up drug approval at the FDA. Reuters reports that some companies worry that a less strict FDA will make it harder for them to get insurance coverage for pricey new medicines.